Literature DB >> 10767823

Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas.

R J Longman1, J Douthwaite, P A Sylvester, D O'Leary, B F Warren, A P Corfield, M G Thomas.   

Abstract

BACKGROUND: MUC5AC is a secreted mucin aberrantly expressed by polypoid colorectal adenomas. It has been hypothesised that the "normal" surrounding colorectal mucosa expresses MUC5AC as a field change phenomenon that can be used to predict adenoma recurrence following resection. AIM: To determine if there is a field change of de novo MUC5AC expression in histologically normal rectal mucosa adjacent to villous and tubulovillous adenomas, and thus whether MUC5AC expression can be used as a marker of early tumour recurrence.
METHODS: In a prospective cohort study paired mucosal biopsies of adenomatous and macroscopically "normal" mucosa were obtained from 11 patients with villous and 11 patients with tubulovillous adenomas who underwent primary resection for purpose of cure. The tissues were studied to determine MUC5AC gene expression by immunohistochemistry and in situ hybridisation. Patients were followed up by flexible sigmoidoscopy to detect the presence of early local recurrence.
RESULTS: 10 villous adenomas showed mature MUC5AC glycoprotein and all 11 expressed MUC5AC mRNA. Five tubulovillous adenomas showed mature MUC5AC glycoprotein and 10 expressed MUC5AC mRNA. Neoexpression of the MUC5AC mucin gene was not detected in any of the mucosal biopsies taken adjacent to either villous or tubulovillous adenomas, even in three patients with early, locally recurrent disease.
CONCLUSIONS: Aberrant MUC5AC gene expression is not a "field change" in the colorectal mucosa in patients with rectal adenomas and therefore cannot be used to predict local recurrence of villous and tubulovillous adenomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767823      PMCID: PMC1763292          DOI: 10.1136/jcp.53.2.100

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  38 in total

1.  Endoscopic transanal resection of rectal tumours--a preliminary report of its use.

Authors:  A R Berry; R G Souter; W B Campbell; N J Mortensen; M G Kettlewell
Journal:  Br J Surg       Date:  1990-02       Impact factor: 6.939

2.  An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon.

Authors:  P A Dawson; M I Filipe
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

3.  Treatment of sessile villous and tubulovillous adenomas of the rectum: experience of St. Mark's Hospital. 1963-1972.

Authors:  J P Thomson
Journal:  Dis Colon Rectum       Date:  1977-09       Impact factor: 4.585

Review 4.  Mucins in the human gastrointestinal epithelium: a review.

Authors:  M I Filipe
Journal:  Invest Cell Pathol       Date:  1979 Jul-Sep

5.  Surgical access to the rectum--a transsphincteric exposure.

Authors:  A Y Mason
Journal:  Proc R Soc Med       Date:  1970

6.  Villous adenomas of the colon and rectum.

Authors:  M R Jahadi; A Baldwin
Journal:  Am J Surg       Date:  1975-12       Impact factor: 2.565

7.  Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.

Authors:  J Bara; R Gautier; N Daher; H Zaghouani; C Decaens
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Villous tumours of the large bowel.

Authors:  S G Pollard; R Macfarlane; W G Everett
Journal:  Br J Surg       Date:  1988-09       Impact factor: 6.939

9.  Study of the histochemical changes in mucus from normal and tumour bearing mucosa in patients with colorectal cancer.

Authors:  N A Habib; P M Dawson; M A Blount; S Cox; T Krausz; C B Wood
Journal:  Eur J Surg Oncol       Date:  1985-09       Impact factor: 4.424

10.  Mucosal field change in colorectal cancer.

Authors:  P M Dawson; N A Habib; H C Rees; C B Wood
Journal:  Am J Surg       Date:  1987-03       Impact factor: 2.565

View more
  4 in total

1.  Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis.

Authors:  Rob J Longman; Richard Poulsom; Anthony P Corfield; Bryan F Warren; Nicholas A Wright; Michael G Thomas
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

Review 2.  What role do mucins have in the development of laryngeal squamous cell carcinoma? A systematic review.

Authors:  Fabian Sipaul; Martin Birchall; Anthony Corfield
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-28       Impact factor: 2.503

3.  Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.

Authors:  N Myerscough; P A Sylvester; B F Warren; S Biddolph; P Durdey; M G Thomas; I Carlstedt; A P Corfield
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

4.  Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.

Authors:  Kristin Wallace; Georges J El Nahas; Christine Bookhout; Jessica E Thaxton; David N Lewin; Nana Nikolaishvili-Feinberg; Stephanie M Cohen; J Grant Brazeal; Elizabeth G Hill; Jennifer D Wu; John A Baron; Alexander V Alekseyenko
Journal:  Cancer Prev Res (Phila)       Date:  2021-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.